1. Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma--an update. CA Cancer J Clin. 2015;65:401-21

https://doi.org/10.3322/caac.21293

PMid:26215712 

2. Togni L, Caponio VCA, Zerman N, Troiano G, Zhurakivska K, Lo Muzio L, et al. The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker. Cancers (Basel). 2022;14:3571.

https://doi.org/10.3390/cancers14153571

PMid:35892830 PMCid:PMC9332070

3. Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L, et al. Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011;40:545-51.

https://doi.org/10.1111/j.1600-0714.2011.01041.x

PMid:21481005 PMCid:PMC3135705

4. Mäkitie AA, Almangush A, Rodrigo JP, Ferlito A, Leivo I. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Head Neck. 2019;41:3712-18.

https://doi.org/10.1002/hed.25872

PMid:31328847 

5. Bielenberg DR, Zetter BR. The Contribution of Angiogenesis to the Process of Metastasis. Cancer J. 2015;21:267-73.

https://doi.org/10.1097/PPO.0000000000000138

PMid:26222078 PMCid:PMC4670555

6. Almahmoudi R, Kasanen M, Sieviläinen M, Salem A, Pirinen M, Salo T, et al. Prognostic value of blood and lymphatic vessel markers in tongue cancer: A systematic review. Cancer Sci. 2019;110:3424-33.

https://doi.org/10.1111/cas.14189

PMid:31495050 PMCid:PMC6824997

7. Leão PLR, Marangon Junior H, Melo VVM, Caixeta ÂB, Souza PEA, de Aguiar MCF, et al. Reproducibility, repeatability, and level of difficulty of two methods for tumor budding evaluation in oral squamous cell carcinoma. J Oral Pathol Med. 2017;46:949-55.

https://doi.org/10.1111/jop.12578

PMid:28383823 

8. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: Applications to assessment of adaptive behavior. Am J Ment Defic. 1981;86:127-37.

PMid:7315877

9. Lin NN, Wang P, Zhao D, Zhang FJ, Yang K, Chen R. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma. J Oral Pathol Med. 2017;46:21-30.

https://doi.org/10.1111/jop.12452

PMid:27229731 

10. Ho JW, Poon RT, Sun CK, Xue WC, Fan ST. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol. 2005;11:176-81.

https://doi.org/10.3748/wjg.v11.i2.176

PMid:15633211 PMCid:PMC4205397

11. Ingaleshwar PS, Pandit S, Desai D, Redder CP, Shetty AS, Mithun KM. Immunohistochemical analysis of angiogenesis by CD34 and mast cells by toluidine blue in different grades of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2016;20:467-73.

https://doi.org/10.4103/0973-029X.190950

PMid:27721613 PMCid:PMC5051296

12. Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Microvessel density in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2018;275:1845-51.

https://doi.org/10.1007/s00405-018-4996-2

PMid:29748768 PMCid:PMC5992238

13. Kathuriya PT, Bartake AR, Palaskar SJ, Narang BR, Patil SS, Pawar RB. CD34 and mast cell analysis in normal oral mucosa and different grades of oral squamous cell carcinoma: a comparative study. J Clin Diagn Res. 2015;9:ZC61-4.

https://doi.org/10.7860/JCDR/2015/12656.6223

PMid:26417554 PMCid:PMC4573039

14. Shao Z, Zhang WF, Chen XM, Shang ZJ. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol. 2008;44:1110-7.

https://doi.org/10.1016/j.oraloncology.2008.01.018

PMid:18485799 

15. Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, et al. Prognostic significance of amino‐acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer. 2014;110:2506-13.

https://doi.org/10.1038/bjc.2014.178

PMid:24762957 PMCid:PMC4021522

16. Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer. 2007;110:1287-94.

https://doi.org/10.1002/cncr.22900

PMid:17674352 

17. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC. High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope. 2006;116:1175-9.

https://doi.org/10.1097/01.mlg.0000224338.56902.28

PMid:16826056 

18. De Sousa SF, Gleber-Netto FO, de Oliveira-Neto HH, Batista AC, Nogueira Guimarães Abreu MH, de Aguiar MC. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. Appl Immunohistochem Mol Morphol. 2012;20:588-94.

https://doi.org/10.1097/PAI.0b013e31824bb3ea

PMid:22495364 

19. Bànkfalvi A, Piffkò J. Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med. 2000;29:291-8.

https://doi.org/10.1034/j.1600-0714.2000.290701.x

PMid:10947243 

20. Marangon Junior H, Leão PLR, Melo VVM, Caixeta ÂB, Souza PEA, de Aguiar MCF, et al. Cell proliferation is associated with intensity of tumor budding in oral squamous cell carcinoma. J Oral Pathol Med. 2018;47:128-35.

https://doi.org/10.1111/jop.12653

PMid:29052910 

21. Marangon Junior H, Melo VVM, Caixeta ÂB, Souto GR, Souza PEA, de Aguiar MCF, et al. Immunolocalization of cancer stem cells marker aldh1 and its association with tumor budding in oral squamous cell carcinoma. Head Neck Pathol. 2019;13:535-42.

https://doi.org/10.1007/s12105-018-0985-4

PMid:30430416 PMCid:PMC6854139

22. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420-8.

https://doi.org/10.1172/JCI39104

PMid:19487818 PMCid:PMC2689101

23. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor budding: the name is EMT. Partial EMT. J Clin Med. 2016;29:E51.

https://doi.org/10.3390/jcm5050051

PMid:27136592 PMCid:PMC4882480

24. Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, et al. Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer. Head Neck. 2014;36:811-8.

https://doi.org/10.1002/hed.23380

PMid:23696499 PMCid:PMC4229066

25. Yamakawa N, Kirita T, Umeda M, Yanamoto S, Ota Y, Otsuru M, et al. Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early‐stage tongue squamous cell carcinoma. J Surg Oncol. 2019;119:370-8.

https://doi.org/10.1002/jso.25334

PMid:30548537 PMCid:PMC6590300

26. Almangush A, Pirinen M, Heikkinen I, Mäkitie AA, Salo T, Leivo I. Tumour budding in oral squamous cell carcinoma: a meta-analysis. Br J Cancer. 2018;118:577-86.

https://doi.org/10.1038/bjc.2017.425

PMid:29190636 PMCid:PMC5830589

27. Pammar C, Nayak RS, Kotrashetti VS, Hosmani J. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study. J Cancer Res Ther. 2018;14:983-8.

https://doi.org/10.4103/0973-1482.181186

PMid:30197335 

28. Almangush A, Leivo I, Siponen M, Sundquist E, Mroueh R, Mäkitie AA, et al. Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies. Virchows Arch. 2018;472:231-6.

https://doi.org/10.1007/s00428-017-2212-1

PMid:28766010 

29. Seki M, Sano T, Yokoo S, Oyama T. Histologic assessment of tumor budding in preoperative biopsies to predict nodal metastasis in squamous cell carcinoma of the tongue and floor of the mouth. Head Neck. 2016;38:E1582-90.

https://doi.org/10.1002/hed.24282

PMid:26595238 

30. Almangush A, Youssef O, Pirinen M, Sundström J, Leivo I, Mäkitie AA. Does evaluation of tumour budding in diagnostic biopsies have a clinical relevance? A systematic review. Histopathology. 2019;74:536-44.

https://doi.org/10.1111/his.13793

PMid:30450728